Skip to main content Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Minutes of Proceedings

42nd Parliament, 1st Session
Meeting No. 39
Thursday, February 2, 2017, 11:02 a.m. to 1:01 p.m.
Presiding
Bill Casey, Chair (Liberal)

Library of Parliament
• Karin Phillips, Analyst
• Marlisa Tiedemann, Analyst
Alberta Blue Cross
• Dianne Balon, Vice President, Government
• Margaret Wurzer, Senior Manager, Benefit and Product Development
Department of National Defence
• Cdr Sylvain Grenier, Senior Staff Officer, Pharmacy Services
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on March 7, 2016, the Committee resumed its study of the Development of a National Pharmacare Program.

Dianne Balon and Commander Sylvain Grenier made statements and, with Margaret Wurzer, answered questions.

At 12:13 p.m., the sitting was suspended.

At 12:19 p.m., the sitting resumed.

House of Commons
• Randy Boissonnault, M.P., Edmonton Centre
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on Tuesday, September 20, 2016, the Committee resumed its study of the Current Blood Donation Restrictions on Men Who Have Sex with Men.

The witness made a statement and answered questions.

At 12:50 p.m., the sitting was suspended.

At 12:52 p.m., the sitting resumed.

The Committee proceeded to the consideration of matters related to Committee business.

Motion

John Oliver moved, — That, with respect to Bill C-37, An Act to amend the Controlled Drugs and Substances Act and to make related amendments to other Acts:

a. the Clerk of the Committee write immediately to each Member who is not a member of a caucus represented on the Committee and any independent Members to inform them that the Committee will begin the study of the Bill and to invite them to prepare and submit any proposed amendments, which they would suggest that the Committee consider during the clause-by-clause study of the Bill;

b. members of the Committee as well as Members who are not a member of a caucus represented on the Committee and independent Members should submit their proposed amendments to the Clerk of the Committee no later than Tuesday, February 7, 2017, at 4:00 p.m.;

c. the Committee proceed with the clause-by-clause consideration of C-37 no later than Thursday, February 9, 2017;

d. the Chair may limit debate on each clause to a maximum of five minutes per party, per clause; and

e. if the Committee has not completed clause-by-clause consideration of Bill C-37 by 5:00 p.m. on Thursday, February 9, 2017, all remaining amendments submitted to the Committee shall be deemed moved, the Chair shall put every question, forthwith and successively, without further debate or amendment on all remaining clauses and amendments submitted to the Committee, as well as each and every question necessary to dispose of clause-by-clause consideration of the Bill, as well as all questions necessary to report the Bill to the House and to order the Chair to report the Bill to the House no later than Monday, February 13, 2017.

The question was put on the motion and it was agreed to, by a show of hands: YEAS: 7; NAYS: 0.

At 1:01 p.m., the Committee adjourned to the call of the Chair.



David Gagnon
Clerk of the Committee